RxDoctor Payments Data

Benjamin Proto, DPM

Podiatrist · Newport News, VANPI 1073506291

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $22,475 of the $25,774 with a category attached, or 87.2%. Globus Medical accounts for 87.2% of it on its own, with 8 other manufacturers making up the rest. Among podiatrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,774in general payments, 2019–2025

Across 75 payments — averaging $343.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$22K
  • Stryker$3K
  • Access Pro Medical, LLC$168
  • Medshape, Inc.$150
  • Bioventus LLC$136
  • Paragon 28, Inc.$59
  • plus $45 from 3 others
$14,889in research payments, 2019–2025

Across 3 payments — averaging $4963.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Globus Medical$15K

What the payments were for

  • Royalty or licence$22,47587%
  • Travel & lodging$1,3455%
  • Food & beverage$1,9558%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,774 in reported general payments places this provider in the 95th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$450,148
Medicare patients
787
Services billed
11,580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone127$766
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen58$648
Cephalexin47$277
Diclofenac Sodium61$253
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$149
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim33$108
Terbinafine Hcl11$80
Meloxicam11$24

Paid to pharmacies, not to this prescriber.

Other podiatrist in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →